Biomarker study for exacerbation predictive markers in patients with COVID-19

Biomarker study for exacerbation predictive markers in patients with COVID-19 - Biomarker study in patients with COVID-19

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044212

Enrollment

200

Registered

2021-05-14

Start date

2021-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with COVID-19

Exclusion criteria

Exclusion criteria: 1) Patients judged by investigators to have an active inflammatory disease other than COVID-19 2) Patients using anticoagulants at the time of diagnosis of COVID-19

Design outcomes

Primary

Measure	Time frame
Identifying predictors of exacerbations in blood from patients with COVID-19	—

Countries

Japan

Contacts

Public ContactHideharu Kimura

Kanazawa University Hospital Respiratory Medicine

hkimura3625@staff.kanazawa-u.ac.jp076-265-2000

Outcome results